April 15th, 2025
Coronavirus Updates - Page 2
European Stocks Respond to Oxford-AstraZeneca Vaccine Approval in UK
By John K. Kumi
December 30th, 2020
According to current data, the AstraZeneca PLC stock (LON: AZN) recorded about a 1.3% gain soon after the approval was finalized on top of the previous 3.3% gain.
Stock Market Closes High as President Trump Assents to COVID-19 Stimulus Bill
By Godfrey Benjamin
December 29th, 2020
Economists from Goldman Sachs Group have revised their Q1 GDP forecast to see a growth of 5% though earlier they expected a 3% increase.
AZN Stock Up 4% in Pre-Market as AstraZeneca Vaccine Nears UK Approval
By John K. Kumi
December 28th, 2020
Pascal Soriot, the Chief Executive of AstraZeneca revealed that the vaccine is as effective as Pfizer and can be a strong protector against the new variant of the virus which is very contagious.
Stock Market Reacts as Donald Trump Signs $2.3T Relief Package Bill
By John K. Kumi
December 28th, 2020
Just as expected, the market has reacted to this news. The S&P futures (INDEXSP: INX) recorded a surge of 0.62% right after the Christmas holiday.
Trump Refuses to Sign Covid-19 Bill, Demands Bigger Stimulus Checks
By Mercy Tukiya Mutanya
December 23rd, 2020
The relief package incorporates, among others, increased jobless benefits, small business loans, education funding, the $600 stimulus checks and funding to aid the supply and distribution of Covid-19 vaccines.
Dow Jones, S&P 500 Take Plunge as New Coronavirus Strain Emerges
By Godfrey Benjamin
December 21st, 2020
The Dow Jones has gained 5.8% this year while the S&P 500 has rallied 14.8% and the Nasdaq Composite comes off with the biggest pump with a 42.2% surge.
Congress Approves $900B COVID-19 Stimulus After Months of Negotiations
By Bhushan Akolkar
December 21st, 2020
After months of negotiations, Congress finally approves a $900 billion stimulus package to fight the ongoing COVID-19 crisis. The daily cases in the US peaked above $400,000 last Friday.
Pounds Sterling Takes Hit as UK Discovers New COVID-19 Strain and Brexit Trade Talks Deadlock
By Godfrey Benjamin
December 21st, 2020
The ongoing Brexit trade negotiations hit another deadlock further contributing to the decline seen in the British Pound Sterling.
Morgan Stanley Downgrades Moderna (MRNA) Stock Before Its Meeting with FDA Today
By Bhushan Akolkar
December 17th, 2020
Morgan Stanley has asked investors not to make any fresh entry in MRNA stock citing potential downside in the short-term. Moderna is having a meeting with the FDA officials later today for approval of its COVID-19 vaccine candidate.
Global Stocks Bounce amid COVID-19 Vaccine Rollout
By Godfrey Benjamin
December 14th, 2020
While the vaccines have given a hint of hope for the economic recovery of most countries including the UK, the ongoing post-Brexit trade talks also have a subtle influence on the global stock market.
PFE Stock Rises on FDA Authorization Pfizer COVID-19 Vaccine for Emergency Use, US to Immunize 100 Million by End of March
By Darya Rudz
December 14th, 2020
According to the FDA, Pfizer’s COVID-19 vaccine is given as two shots administered 21 days apart. One dose is to prime the body, and then a few weeks later, the second dose is to boost the response.
FDA Approves Pfizer Vaccine, 3 Million Doses to Ship in a Week
By Steven Msoh
December 12th, 2020
The Food and Drug Administration has approved the Pfizer COVID-19 vaccine, paving way for close to three million highly-vulnerable Americans to receive the vaccine next week.
Sanofi-GSK COVID-19 Vaccine Rollout Delayed Due to Low Efficacy with Older Patients
By Steve Muchoki
December 11th, 2020
Apparently, Sanofi noted that the vaccine was more responsive to younger patients, particularly those below 49 years.
Increase in COVID-19 Cases Puts Pressure on Markets, Stock Futures Fall
By Bhushan Akolkar
December 8th, 2020
All three futures – Dow Jones, S&P 500, and Nasdaq 100 – opened lower today on Tuesday. The European market also remained under pressure on rising COVID-19 cases.
Bill Gates: about Six COVID-19 Vaccines Could Be Available by Spring 2021
By Godfrey Benjamin
December 8th, 2020
Pfizer in collaboration with BioNTech is the only COVID-19 developer whose vaccine has already secured an Emergency Use Authorization in the United Kingdom.